Related Experiment Videos
Antibiotic resistance and therapeutic options in lower respiratory tract infections
1Enfermedades Infecciosas-HIV, Hospital G.U. Gregorio Marañón, Madrid, Spain. ebouza@microb.net
Abstract:
The emergence of some strains of common pathogens of community acquired pneumonia resistant to one or more of the frequently used antimicrobials is becoming widespread. The clinical significance and implications of these resistance patterns are, however, unclear. Studies of the clinical progress of patients with pneumonia or bacteraemia infected with penicillin-resistant organisms show that patients frequently recover when treated with penicillins or cephalosporins. Beta-Lactam drugs and macrolides are still associated with clinical success in lower respiratory tract infections despite increasing resistance to these agents in vitro. Therefore, when making therapeutic choices, in vitro resistance data cannot always be used to predict clinical outcome. Infections caused by resistant organisms can usually be successfully treated using traditional therapeutic approaches.
Insights
Antimicrobial resistance in community acquired pneumonia is rising, but clinical outcomes often remain favorable. Traditional treatments can still effectively manage infections caused by resistant pathogens.
Area of Science:
- Microbiology
- Infectious Diseases
- Clinical Medicine
Background:
- Increasing prevalence of antimicrobial resistance in community acquired pneumonia (CAP) pathogens.
- Uncertainty regarding the clinical impact of observed antimicrobial resistance patterns.
Purpose of the Study:
- To clarify the clinical significance of antimicrobial resistance in CAP.
- To evaluate the effectiveness of traditional antimicrobial agents against resistant pathogens.
Main Methods:
- Review of clinical progress in patients with pneumonia or bacteremia caused by penicillin-resistant organisms.
- Analysis of treatment outcomes with beta-lactam drugs and macrolides in lower respiratory tract infections.
Main Results:
- Patients infected with penicillin-resistant organisms frequently recover with penicillin or cephalosporin treatment.
- Beta-lactam drugs and macrolides show continued clinical success in lower respiratory tract infections despite in vitro resistance.
- In vitro resistance data may not accurately predict clinical outcomes.
Conclusions:
- In vitro antimicrobial resistance does not always correlate with clinical treatment failure.
- Traditional therapeutic approaches remain effective for treating infections caused by resistant organisms.
- Clinical outcomes for resistant infections can often be successfully managed with established treatments.